Karl Herholz < Karl Kieburtz < Karl Knop

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]

Ident.	Authors (with country if any)	Title
000332 (2015)	Karl Kieburtz [États-Unis] ; C Warren Olanow [États-Unis]	Advances in clinical trials for movement disorders.
000432 (2014)	Leigh J. Beglinger [États-Unis] ; William H. Adams ; Douglas Langbehn ; Jess G. Fiedorowicz ; Ricardo Jorge ; Kevin Biglan ; John Caviness ; Blair Olson ; Robert G. Robinson ; Karl Kieburtz ; Jane S. Paulsen	Results of the citalopram to enhance cognition in Huntington disease trial.
000532 (2014)	Radu Constantinescu [États-Unis] ; Jordan Elm ; Peggy Auinger ; Saloni Sharma ; Erika F. Augustine ; Laith Khadim ; Karl Kieburtz	Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial.
000553 (2014)	C Warren Olanow [États-Unis] ; Karl Kieburtz ; Fabrizio Stocchi	Initiating levodopa therapy for Parkinson's disease.
000702 (2014)	Caroline M. Tanner [États-Unis] ; Cheryl C. Meng ; Bernard Ravina ; Anthony Lang ; Roger Kurlan ; Kenneth Marek ; David Oakes ; John Seibyl ; Emily Flagg ; Lisa Gauger ; Dolores D. Guest ; Christopher G. Goetz ; Karl Kieburtz ; Diane Dieuliis ; Stanley Fahn ; Robin A. Elliott ; Ira Shoulson	A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study.
000871 (2013)	Karl Kieburtz [États-Unis] ; Kathryn B. Wunderle	Parkinson's disease: evidence for environmental risk factors.
000A03 (2013)	C. Warren Olanow [États-Unis] ; Karl Kieburtz ; Olivier Rascol ; Werner Poewe [Autriche] ; Anthony H. Schapira ; Murat Emre ; Helena Nissinen ; Mika Leinonen ; Fabrizio Stocchi	Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
000C34 (2012)	Scott Y H. Kim [États-Unis] ; Raymond De Vries ; Robert G. Holloway ; Renee Wilson ; Sonali Parnami ; H Myra Kim ; Samuel Frank ; Karl Kieburtz	Sham surgery controls in Parkinson's disease clinical trials: views of participants.
000C89 (2012)	Charles S. Venuto [États-Unis] ; Andrew Mcgarry ; Qing Ma ; Karl Kieburtz	Pharmacologic approaches to the treatment of Huntington's disease.
000E77 (2012)	Scott Y H. Kim [États-Unis] ; Renee M. Wilson ; H Myra Kim ; Robert G. Holloway ; Raymond G. De Vries ; Samuel A. Frank ; Karl Kieburtz	Comparison of enrollees and decliners of Parkinson disease sham surgery trials.
001009 (2011)	Karl Kieburtz [États-Unis]	Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial.
001237 (2011)	C Warren Olanow [États-Unis] ; Kathryn B. Wunderle ; Karl Kieburtz	Milestones in movement disorders clinical trials: advances and landmark studies.
001556 (2010)	Peggy Auinger [États-Unis] ; Karl Kieburtz ; Michael P. Mcdermott	The relationship between uric acid levels and Huntington's disease progression.
001626 (2010)	H Christopher Hyson ; Karl Kieburtz ; Ira Shoulson ; Michael Mcdermott ; Bernard Ravina ; Elisabeth A. De Blieck ; Merit E. Cudkowicz ; Robert J. Ferrante ; Peter Como ; Sam Frank ; Carol Zimmerman ; Merit E. Cudkowicz ; Kimberly Ferrante ; Kristyn Newhall ; Danna Jennings ; Tammie Kelsey ; Francis Walker ; Vicki Hunt ; Susan Daigneault ; Michele Goldstein ; Joseph Weber ; Arthur Watts ; M Flint Beal ; Susan E. Browne ; Linda J. Metakis	Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects.
001951 (2010)	C Warren Olanow [États-Unis] ; Karl Kieburtz	Defining disease-modifying therapies for PD--a road map for moving forward.
001A08 (2010)	Steven R. Schwid [États-Unis] ; Janice Bausch ; David Oakes ; Lynn Schuchter ; Caroline Tanner ; Misser Forrest ; Anthony E. Lang ; Ira Shoulson ; Ira Shoulson ; Christopher Hyson ; David Oakes ; Emily Flagg ; Alice Rudolph ; Karl Kieburtz ; Anthony Lang ; Stanley Fahn ; Lisa Gauger ; Christopher Goetz	Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
001B08 (2009)	Peng Huang [États-Unis] ; Christopher G. Goetz ; Robert F. Woolson ; Barbara Tilley ; Douglas Kerr ; Yuko Palesch ; Jordan Elm ; Bernard Ravina ; Kenneth J. Bergmann ; Karl Kieburtz	Using global statistical tests in long-term Parkinson's disease clinical trials.
001F83 (2009)	Bernard Ravina [États-Unis] ; Caroline Tanner ; Diane Dieuliis ; Shirley Eberly ; Emily Flagg ; Wendy R. Galpern ; Stanley Fahn ; Christopher G. Goetz ; Stephen Grate ; Roger Kurlan ; Anthony E. Lang ; Kenneth Marek ; Karl Kieburtz ; David Oakes ; Robin Elliott ; Ira Shoulson	A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
002031 (2008)	Bernard Ravina [États-Unis] ; Megan Romer ; Radu Constantinescu ; Kevin Biglan ; Alicia Brocht ; Karl Kieburtz ; Ira Shoulson ; Michael P. Mcdermott	The relationship between CAG repeat length and clinical progression in Huntington's disease.
002309 (2008)	Samuel A. Frank [États-Unis] ; Renee Wilson ; Robert G. Holloway ; Carol Zimmerman ; Derick R. Peterson ; Karl Kieburtz ; Scott Y H. Kim	Ethics of sham surgery: perspective of patients.
002727 (2007)	Radu Constantinescu [États-Unis] ; Megan Romer ; Karl Kieburtz	Malignant melanoma in early Parkinson's disease: the DATATOP trial.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Karl Kieburtz" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Karl Kieburtz" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Karl Kieburtz
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024